Advisors urged to look past headline yields as liquidity risks, valuation opacity, and widening manager gaps reshape the ...

Structure Therapeutics' Phase 2 data for Aleniglipron show 16% weight loss at 44 weeks with strong tolerability and no safety signals. Read more on GPCR stock.

Placebo-adjusted mean weight loss of 16.3% (39 lbs) at 180 mg and 16.0% (37 lbs) at 240 mg at 44 weeks with no evidence of weight loss plateau in ACCESS II, demonstrating highest efficacy among oral ...

Glucagon-like peptide 1 (GLP1, 7-36) molecule The glucagon like peptide-1 receptor has a strong effect on the management of type 2 diabetes mellitus. · BioPharma Dive · Getty Images A pill from ...

As a drug moves through research and regulatory processes, any mistakes in the data will be compounded. Small gaps that a ...

By Nora Buli and Emily Chow OSLO/SINGAPORE, March 27 (Reuters) - Russia's threat to halt liquefied natural gas (LNG) ...

Explore the implications of China's AI education manifesto for the global landscape, particularly India's educational ...

LLMs are quietly reshaping data journalism workflows at The Hindu, helping reporters process vast document sets, write ...

Artificial intelligence does not exist in a vacuum. Behind every well-trained model, every accurate recommendation engine, ...

This article is authored by Antony Nellissery, head, Sterlite EdIndia Foundation.